cell analysis
LineaRx Acquires Cancer Cell Analysis Firm Vitatex
LineaRx was formed last year to commercialize Applied DNA Sciences' technologies for DNA design, manufacture, and chemical modification by large scale PCR.
Accelerate Diagnostics Q2 Revenues More Than Double
The firm reported that it has signed contracts for a total of 430 instruments, while commercial placements grew to 118 across the globe. Â
Beckman Coulter Files for US Clearance of Sepsis Indicator
The Early Sepsis Indicator is intended to provide clinicians information about sepsis and the risk of developing sepsis in patients in acute care settings.
CEO Anders Rylander said the company will initially market its DiviTum assay for breast cancer cases, though it could be used to monitor cell proliferation in all cancer types.
RareCyte Completes $30M Private Financing
The firm plans to use the funding to expand commercial sales efforts, advance CDx partnerships, build its regulatory infrastructure, and explore new R&D avenues.